atorvastatin teva pharma 80 mg
teva pharmaceuticals slovakia s.r.o., slovensko - atorvastatín - 31 - hypolipidaemica
pemetrexed waverley pharma 500 mg prášok na koncentrát na infúzny roztok
waverley pharma europe limited, Írsko - pemetrexed - 44 - cytostatica
pemetrexed waverley pharma 100 mg prášok na koncentrát na infúzny roztok
waverley pharma europe limited, Írsko - pemetrexed - 44 - cytostatica
diclofenac dr. müller pharma 100 mg čapíky
dr. müller pharma s.r.o., Česká republika - diklofenak - 29 - antirheumatica, antiphlogistica, antiuratica
abiraterone g.l. pharma 500 mg filmom obalené tablety
g.l. pharma gmbh, rakúsko - abiraterón - 44 - cytostatica
abiraterone g.l. pharma 250 mg tablety
g.l. pharma gmbh, rakúsko - abiraterón - 44 - cytostatica
teriflunomide g.l. pharma 14 mg filmom obalené tablety
g.l. pharma gmbh, rakúsko - teriflunomid - 59 - immunopraeparata
flurbiprofen geiser pharma
geiser pharma s.l., Španielsko - flurbiprofén - 69 - otorhinolaryngologica
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastické činidlá - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
latanoprost polpharma 50 mikrogramov/ml
zaklady farmaceutyczne polpharma sa, poľsko - latanoprost - 64 - ophthalmologica